BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 22800695)

  • 21. [Expression of C-erbB-2 oncogene mRNA in salivary gland tumors].
    Sun H; Wu S; Ouyang J
    Zhonghua Kou Qiang Yi Xue Za Zhi; 1999 Sep; 34(5):289-91. PubMed ID: 11776895
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Salivary gland cancers: biology and molecular targets for therapy.
    Bell D; Hanna EY
    Curr Oncol Rep; 2012 Apr; 14(2):166-74. PubMed ID: 22246609
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor-associated glycoprotein 72 (TAG-72) expression in salivary gland neoplasia: an immunohistochemical study using the monoclonal antibody (MAb) CC49.
    Epivatianos A; Poulopoulos A; Kayavis I; Papanayotou P
    Oral Dis; 2000 Mar; 6(2):112-7. PubMed ID: 10702789
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinicopathological features of lung salivary gland-type tumors].
    Yan LM; Di JT; Nong L; Liang L; Wang W; Li X; Xiong Y; Li T
    Zhonghua Bing Li Xue Za Zhi; 2019 Dec; 48(12):928-933. PubMed ID: 31818065
    [No Abstract]   [Full Text] [Related]  

  • 25. Primary Pulmonary Salivary Gland-type Tumors: A Review and Update.
    Falk N; Weissferdt A; Kalhor N; Moran CA
    Adv Anat Pathol; 2016 Jan; 23(1):13-23. PubMed ID: 26645458
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic implications of NUMB immunoreactivity in salivary gland carcinomas.
    Maiorano E; Favia G; Pece S; Resta L; Maisonneuve P; Di Fiore PP; Capodiferro S; Urbani U; Viale G
    Int J Immunopathol Pharmacol; 2007; 20(4):779-89. PubMed ID: 18179751
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Recent advances in adenoid cystic carcinoma of minor salivary gland].
    Zhou Q; Liu HG
    Zhonghua Bing Li Xue Za Zhi; 2011 Nov; 40(11):783-7. PubMed ID: 22336169
    [No Abstract]   [Full Text] [Related]  

  • 28. MYB Translocation Status in Salivary Gland Epithelial-Myoepithelial Carcinoma: Evaluation of Classic, Variant, and Hybrid Forms.
    Bishop JA; Westra WH
    Am J Surg Pathol; 2018 Mar; 42(3):319-325. PubMed ID: 29135517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fusion oncogenes in salivary gland tumors: molecular and clinical consequences.
    Stenman G
    Head Neck Pathol; 2013 Jul; 7 Suppl 1(Suppl 1):S12-9. PubMed ID: 23821214
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current diagnosis and treatment of salivary gland-type tumors of the lung.
    Horio Y; Kuroda H; Masago K; Matsushita H; Sasaki E; Fujiwara Y
    Jpn J Clin Oncol; 2024 Mar; 54(3):229-247. PubMed ID: 38018262
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent developments in the pathology of primary pulmonary salivary gland-type tumours.
    Naso JR; Roden AC
    Histopathology; 2024 Jan; 84(1):102-123. PubMed ID: 37694812
    [TBL] [Abstract][Full Text] [Related]  

  • 32. t(11;19) translocation and CRTC1-MAML2 fusion oncogene in mucoepidermoid carcinoma.
    O'Neill ID
    Oral Oncol; 2009 Jan; 45(1):2-9. PubMed ID: 18486532
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNA flow cytometry of reclassified subtypes of malignant salivary gland tumors.
    Bang G; Donath K; Thoresen S; Clausen OP
    J Oral Pathol Med; 1994 Aug; 23(7):291-7. PubMed ID: 7965883
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Molecular markers in salivary gland tumors: their use in diagnostic and prognostic workup].
    Fehr A; Stenman G; Bullerdiek J; Löning T
    Pathologe; 2009 Nov; 30(6):466-71. PubMed ID: 19784654
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mammary analog secretory carcinoma of salivary gland origin with the ETV6 gene rearrangement by FISH: expanded morphologic and immunohistochemical spectrum of a recently described entity.
    Connor A; Perez-Ordoñez B; Shago M; Skálová A; Weinreb I
    Am J Surg Pathol; 2012 Jan; 36(1):27-34. PubMed ID: 21989350
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Twenty-seven years of primary salivary gland carcinoma in Wales: an analysis of histological subtype and associated risk factors.
    Leopard D; El-Hitti E; Puttasiddaiah P; Mcleod R; Owens D
    J Laryngol Otol; 2022 Feb; 136(2):167-172. PubMed ID: 35001862
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Salivary gland mucoepidermoid carcinoma is a clinically, morphologically and genetically heterogeneous entity: a clinicopathological study of 40 cases with emphasis on grading, histological variants and presence of the t(11;19) translocation.
    Schwarz S; Stiegler C; Müller M; Ettl T; Brockhoff G; Zenk J; Agaimy A
    Histopathology; 2011 Mar; 58(4):557-70. PubMed ID: 21371076
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunohistochemical study of the expression of fatty acid synthase and Ki-67 in salivary gland tumors.
    do Prado RF; da Silva Machado AL; Colombo CE; Carvalho YR
    J Oral Pathol Med; 2011 Jul; 40(6):467-75. PubMed ID: 21385214
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epidermal growth factor receptor immunoexpression evaluation in malignant salivary gland tumours.
    Monteiro LS; Bento MJ; Palmeira C; Lopes C
    J Oral Pathol Med; 2009 Jul; 38(6):508-13. PubMed ID: 19317849
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Critical regions and spreading of runt-related transcription factor-3 C-phosphate-G (CpG) island methylation in human salivary gland adenoid cystic carcinoma.
    Ge MH; Chen C; Xu JJ; Ling ZQ
    Hum Pathol; 2011 Dec; 42(12):1862-72. PubMed ID: 21658745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.